1. Hypersensitivity reactions to chemotherapy: an EAACI Position Paper
   Mauro Pagani et al, 2022, Allergy CrossRef
2. Dexamethasone/docetaxel/paclitaxel
   , 2013, Reactions Weekly CrossRef
3. Designing Hybrid Onconase Nanocarriers for Mesothelioma Therapy: A Taguchi Orthogonal Array and Multivariate Component Driven Analysis
   Rakesh K. Tekade et al, 2014, Molecular Pharmaceutics CrossRef
4. Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety
   H. Shimada et al, 2015, Japanese Journal of Clinical Oncology CrossRef
5. Safety of nab-paclitaxel following an allergic reaction to paclitaxel: A single institution retrospective study
   Swapna Kochuveettil et al, 2024, Gynecologic Oncology Reports CrossRef
6. Targeting mitotic regulators in cancer as a strategy to enhance immune recognition
   Mateusz Gregorczyk et al, 2023, DNA Repair CrossRef
7. Peritoneal cancer treatment
   Yutaka Yonemura et al, 2014, Expert Opinion on Pharmacotherapy CrossRef
8. Premedication Protocols to Prevent Hypersensitivity Reactions to Chemotherapy: a Literature Review
   Faisal ALMuhizi et al, 2022, Clinical Reviews in Allergy & Immunology CrossRef
9. Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy
   LIYU CHEN et al, 2015, Oncology Letters CrossRef
10. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review
    Matthieu Picard et al, 2015, Clinical Reviews in Allergy & Immunology CrossRef